JiEonPark and other scholars have found that SanG can inhibit the proliferation of non-small cell lung cancer cells and induce their apoptosis through the combination of caspase-3 activation and RPL5-mediated c-Myc inhibition and doxorubicin in their research on the effect of Sangenong (SanG) [9]. The gene discussed is RPL5; the disease is non-small cell lung carcinoma.